Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Lab-grown skin organoids help scientists understand monkeypox infection

Lab-grown skin organoids help scientists understand monkeypox infection

Insilico Medicine to present scientific data on novel anti-cancer assets at major cancer conferences

Insilico Medicine to present scientific data on novel anti-cancer assets at major cancer conferences

Moffitt Cancer Center researchers identify hidden target of ROS1 inhibitor lorlatinib

Moffitt Cancer Center researchers identify hidden target of ROS1 inhibitor lorlatinib

Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics

Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics

AstraZeneca announces winners of the 2023 R&D Postdoctoral Challenge

AstraZeneca announces winners of the 2023 R&D Postdoctoral Challenge

Ensuring raw material quality in drug production and manufacturing

Ensuring raw material quality in drug production and manufacturing

Accelerating drug discovery with analytical R&D solutions

Accelerating drug discovery with analytical R&D solutions

BioLizard launches new BioVerse Platform to accelerate life sciences R&D processes

BioLizard launches new BioVerse Platform to accelerate life sciences R&D processes

Recent Advancements in Cell Based Therapy

Recent Advancements in Cell Based Therapy

HKU-developed antibiotic drug to enter clinical trials in Mainland China

HKU-developed antibiotic drug to enter clinical trials in Mainland China

IU Cancer Center awarded grant to train next generation of cancer drug discovery researchers

IU Cancer Center awarded grant to train next generation of cancer drug discovery researchers

Drug Discovery 2023: A Conversation with Professor Janet Hemingway

Drug Discovery 2023: A Conversation with Professor Janet Hemingway

UK's first-of-its-kind total-body PET imaging platform could enhance quality and speed of drug discovery

UK's first-of-its-kind total-body PET imaging platform could enhance quality and speed of drug discovery

Researchers spearhead a new method to hone in on new cancer drug targets

Researchers spearhead a new method to hone in on new cancer drug targets

Sphere Fluidics’ Cyto-Mine system selected by FairJourney Biologics to advance cell line development workflows

Sphere Fluidics’ Cyto-Mine system selected by FairJourney Biologics to advance cell line development workflows

Ubiquigent collaborates with Imperial College London on DUB probe discovery to facilitate preclinical and clinical target engagement studies

Ubiquigent collaborates with Imperial College London on DUB probe discovery to facilitate preclinical and clinical target engagement studies

AI tool PARMESAN predicts drug-gene interactions for genetic disorders

AI tool PARMESAN predicts drug-gene interactions for genetic disorders

IU cancer researcher receives NCI grant to examine how immune cells support breast cancer development

IU cancer researcher receives NCI grant to examine how immune cells support breast cancer development

Start Codon invites life sciences leaders, founders, and investors to Innovation Showcase 2023

Start Codon invites life sciences leaders, founders, and investors to Innovation Showcase 2023

Optibrium releases powerful metabolism prediction capability in next generation StarDrop software

Optibrium releases powerful metabolism prediction capability in next generation StarDrop software

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.